Weil Company’s Bausch Health BHC Stock Holding History

Weil Company’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,040	Closed	-$23K	–	136
2019 Q3	$23K	Buy	+1,040	New	+$23.8K	0.02%	233

Other funds holding BHC

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Weil Company's BHC Position: Q4 2019 in Review

Weil Company sold out of Bausch Health (BHC) in Q4 2019, closing a stake of 1,040 shares — an estimated $23K sold.

Weil Company first reported a position in BHC in Q3 2019 and held it in 1 quarter. The position peaked at $23K in Q3 2019. 327 funds tracked by Wall St. Rank hold BHC as of Q4 2019.

Weil Company reported no remaining Bausch Health position as of Q4 2019 after selling out during the quarter.
Weil Company sold 1,040 Bausch Health shares in Q4 2019, an estimated $23K.
Weil Company first reported a position in Bausch Health in Q3 2019 and held it in 1 quarter.
Weil Company's Bausch Health position peaked at $23K in Q3 2019.
327 funds tracked by Wall St. Rank held Bausch Health as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.